| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Agile Therapeutics, Inc. | 1,774,319 | 12,385,000 | 55.46% | ||
| 2 | MADRIGAL PHARMACEUTICALS INC | 506,738 | 6,425,000 | 28.77% | ||
| 3 | BERKSHIRE HATHAWAY INC DEL | 8,945 | 1,292,000 | 5.79% | ||
| 4 | CSW INDUSTRIALS INC COM | 11,253 | 364,000 | 1.63% | ||
| 5 | STELLUS CAP INVT CORP | 24,103 | 262,000 | 1.17% | ||
| 6 | PARATEK PHARMACEUTICALS INC | 18,909 | 246,000 | 1.10% | ||
| 7 | DOVER CORP | 3,224 | 237,000 | 1.06% | ||
| 8 | CIDARA THERAPEUTICS INC | 18,425 | 211,000 | 0.94% | ||
| 9 | MEDLEY CAP CORPORATION | 27,357 | 209,000 | 0.94% | ||
| 10 | Strongbridge Biopharma plc | 35,245 | 184,000 | 0.82% | ||
| 11 | American Capital Senior Floating Ltd | 16,339 | 180,000 | 0.81% | ||
| 12 | GARRISON CAP INC | 15,995 | 162,000 | 0.73% | ||
| 13 | CM FIN INC COM | 16,409 | 149,000 | 0.67% | ||
| 14 | MADRIGAL PHARMACEUTICALS INC | 2,057 | 26,000 | 0.12% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-16-016368, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
